
via NYU
COVID-19 Severity Score, Built with Data from China and New York City, Can Help Clinicians Identify the Most At-Risk Patients
A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases. Created by researchers at NYU College of Dentistry, the app uses artificial intelligence (AI) to assess risk factors and key biomarkers from blood tests, producing a COVID-19 “severity score.”
Current diagnostic tests for COVID-19 detect viral RNA to determine whether someone does or does not have the virus—but they do not provide clues as to how sick a COVID-positive patient may become.
“Identifying and monitoring those at risk for severe cases could help hospitals prioritize care and allocate resources like ICU beds and ventilators. Likewise, knowing who is at low risk for complications could help reduce hospital admissions while these patients are safely managed at home,” said John T. McDevitt, PhD, professor of biomaterials at NYU College of Dentistry, who led the research.
“We want doctors to have both the information they need and the infrastructure required to save lives. COVID-19 has challenged both of these key areas.”
Creating a Severity Score
Using data from 160 hospitalized COVID-19 patients in Wuhan, China, the researchers identified four biomarkers measured in blood tests that were significantly elevated in patients who died versus those who recovered: C-reactive protein (CRP), myoglobin (MYO), procalcitonin (PCT), and cardiac troponin I (cTnI). These biomarkers can signal complications that are relevant to COVID-19, including acute inflammation, lower respiratory tract infection, and poor cardiovascular health.
The researchers then built a model using the biomarkers as well as age and sex, two established risk factors. They trained the model using a machine learning algorithm, a type of AI, to define the patterns of COVID-19 disease and predict its severity. When a patient’s biomarkers and risk factors are entered into the model, it produces a numerical COVID-19 severity score ranging from 0 (mild or moderate) to 100 (critical).
The model was validated using data from 12 hospitalized COVID-19 patients from Shenzhen, China, which confirmed that the model’s severity scores were significantly higher for the patients that died versus those who were discharged. These findings are published in Lab on a Chip, a journal of the Royal Society of Chemistry.
As New York City emerged as the epicenter of the pandemic, the researchers further validated the model using data from more than 1,000 New York City COVID-19 patients. To make the tool available and convenient for clinicians, they developed a mobile app that can be used at point-of-care to quickly calculate a patient’s severity score.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 disease severity
- CGTN: How China continues optimizing its COVID-19 response amid other outbreaks
Zhong said they have accumulated much experience in the last round of the COVID-19 epidemic and can transform from normal operations to rapid response to a disease outbreak, including allocating ...
- Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing
Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care Associates, sees something different in his practice since the onset of the COVID-19 pandemic—not just with cancer care, but with cancer itself ...
- Underactive immune response may explain obesity link to COVID-19 severity
Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory ... of Therapeutic Immunology and Infectious Disease (CITIID) and Wellcome Sanger Institute ...
- Predicting the next COVID-19: What we've learned 3 years later
Three years ago, Austin, the United States and the world shut down. Schools went on spring break and didn't return in person until August. Businesses shut down. People started working from home and ...
- Hybrid immunity ups residents’ defense against severe COVID-19, study finds
Nursing home residents infected with COVID-19 prior to vaccination had the strongest protection against severe disease when compared to their peers without such hybrid immunity.
Go deeper with Google Headlines on:
COVID-19 disease severity
[google_news title=”” keyword=”COVID-19 disease severity” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
COVID-19
- Origins Of Covid-19: Two Locations Of Interest
Two specific locations in the Chinese city of Wuhan continue to generate interest Openstreetmap.org Stocks in the financial sector were trading higher along with the broader market early Tuesday, ...
- Appeals court blocks COVID-19 vaccine mandate for US government workers
President Joe Biden’s order that federal employees get vaccinated against COVID-19 was blocked Thursday by a federal appeals court. The 5th U.S. Circuit Court of Appeals in New Orleans rejected ...
- ‘There’s no end in sight’: How COVID-19 changed a Utah teacher’s life
Long COVID-19 changed the life of a Utah high school teacher who believes his breathing difficulties and other symptoms may be neurological, caused by nerve damage.
- COVID-19 damages immune response for some: ‘A big deal’
You have damage that, even in recovery from the infection, you haven’t really recovered your ability to make those CD8+ cells,” Stanford Professor Mark Davis said.
- COVID-19 death rates varied dramatically across US, major analysis finds
A new analysis published Monday found COVID-19 deaths varied dramatically across the U.S. with Arizona having the highest rates and Hawaii having the lowest.
Go deeper with Google Headlines on:
COVID-19
[google_news title=”” keyword=”COVID-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]